Back to top
more

Innovator IBD Breakout Opportunities ETF: (BOUT)

(Delayed Data from NYSE) As of Apr 25, 2024 03:47 PM ET

$33.69 USD

33.69
1,289

+0.28 (0.85%)

Volume: 1,289

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 33.41
Open 33.06
Bid 29.89
Ask 36.23
Day Low-High 33.06-33.78
52wk Low-High 28.58-36.58
Volume 1,289
NAV (month end) 36.41
Premium (+)/Discount (-) (month end)-3.00

Zacks Premium Research for BOUT

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.80%
Dividend (Yield) $0.44 (1.31%)
Issuer INNOVATOR

Benchmark for BOUT

IBD BREAKOUT STOCKS INDEX

The IBD Breakout Stocks Index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond its recent resistance level, with consideration for various market conditions.

Fund Summary for BOUT

INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF

The Innovator IBD Breakout Opportunities ETF seeks to track, before fees and expenses, the performance of the IBD Breakout Stocks Index.